Catherine D Kubiak, MD | |
13145 66th St, Largo, FL 33773-1812 | |
(727) 530-0700 | |
Not Available |
Full Name | Catherine D Kubiak |
---|---|
Gender | Female |
Speciality | Allergy/immunology |
Experience | 14 Years |
Location | 13145 66th St, Largo, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770801953 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | ME116623 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Samuel Gubernick Do Pa | 6002993268 | 3 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
Glioblastoma is the most common of malign brain tumors in adults, and it currently has no cure. Now a research team led by Dr Claudia Barros, from the Plymouth University Peninsula Schools of Medicine and Dentistry and its Brain Tumour Research-funded Centre of Excellence, has secured funding from the Brain Research Trust, which will help to expose novel molecules and their modes of action responsible for the initiation and growth of the disease.
A new study from the University of Illinois confirms a link between Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors.
U.S. Customs and Border Protection officials on Tuesday said that as of Oct. 9 they will no longer seize prescription drugs sent by mail to U.S. residents from Canadian pharmacies, the Wall Street Journal reports (Carreyrou, Wall Street Journal, 10/4).
› Verified 2 days ago
Entity Name | Samuel Gubernick Do Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780877829 PECOS PAC ID: 6002993268 Enrollment ID: O20080411000482 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
Glioblastoma is the most common of malign brain tumors in adults, and it currently has no cure. Now a research team led by Dr Claudia Barros, from the Plymouth University Peninsula Schools of Medicine and Dentistry and its Brain Tumour Research-funded Centre of Excellence, has secured funding from the Brain Research Trust, which will help to expose novel molecules and their modes of action responsible for the initiation and growth of the disease.
A new study from the University of Illinois confirms a link between Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors.
U.S. Customs and Border Protection officials on Tuesday said that as of Oct. 9 they will no longer seize prescription drugs sent by mail to U.S. residents from Canadian pharmacies, the Wall Street Journal reports (Carreyrou, Wall Street Journal, 10/4).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Catherine D Kubiak, MD 13145 66th St, Largo, FL 33773-1812 Ph: (727) 530-0700 | Catherine D Kubiak, MD 13145 66th St, Largo, FL 33773-1812 Ph: (727) 530-0700 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
Glioblastoma is the most common of malign brain tumors in adults, and it currently has no cure. Now a research team led by Dr Claudia Barros, from the Plymouth University Peninsula Schools of Medicine and Dentistry and its Brain Tumour Research-funded Centre of Excellence, has secured funding from the Brain Research Trust, which will help to expose novel molecules and their modes of action responsible for the initiation and growth of the disease.
A new study from the University of Illinois confirms a link between Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors.
U.S. Customs and Border Protection officials on Tuesday said that as of Oct. 9 they will no longer seize prescription drugs sent by mail to U.S. residents from Canadian pharmacies, the Wall Street Journal reports (Carreyrou, Wall Street Journal, 10/4).
› Verified 2 days ago
Dr. Johana Beatriz Castro Wagner, M.D Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 11200 Seminole Blvd Ste 310, Largo, FL 33778 Phone: 727-397-8557 Fax: 727-397-4459 | |
Mandel R Sher, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 11200 Seminole Blvd, Suite 310, Largo, FL 33778 Phone: 727-397-8557 Fax: 727-397-4459 | |
Monroe James King, DO Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 11200 Seminole Blvd, Suite 310, Largo, FL 33778 Phone: 727-397-8557 Fax: 727-397-4459 |